scispace - formally typeset
Search or ask a question
Institution

Hospital Universitario La Paz

HealthcareMadrid, Spain
About: Hospital Universitario La Paz is a healthcare organization based out in Madrid, Spain. It is known for research contribution in the topics: Population & Medicine. The organization has 8960 authors who have published 11499 publications receiving 191509 citations.


Papers
More filters
Journal ArticleDOI
01 Apr 2000-Allergy
TL;DR: The aim was to evaluate the IgE antibody response to beef in suspected meat‐allergic subjects and assess cross‐reactivity of beef with other vertebrate meats.
Abstract: Background: Although beef is a main source of protein in Western diets, very little has been published on allergic reactions to beef or the main allergens implicated in these reactions. The aim was to evaluate the IgE antibody response to beef in suspected meat-allergic subjects and assess cross-reactivity of beef with other vertebrate meats. Methods: Fifty-seven sera from suspected meat-allergic subjects were tested by grid blot for specific IgE antibodies to vertebrate meats (beef, lamb, pork, venison, and chicken), and the patterns of recognition of meat proteins were assessed by immunoblot studies. Results: A 160-kDa band, identified as bovine IgG, was detected in raw beef in 83% (10/12) of beef-allergic subjects but in only 24% of the beef-tolerant subjects. IgE reactivity to a band of similar mol. mass was detected also in lamb and venison, but rarely in pork or chicken. Complete inhibition of the IgE reactivity to the bovine IgG was obtained with lamb, venison, and milk. IgE reactivity to this band also completely disappeared when beef or lamb extracts were separated under reducing conditions, indicating conformational epitopes. Conclusions: Bovine IgG appears to be a major cross-reacting meat allergen that could predict beef allergy. Further studies with oral IgG challenges should be performed to document the conclusion that in vitro reactivity correlates with clinical hypersensitivity. The role of bovine IgG in other bovine products such as milk, dander, or hair must also be studied, and the hypothesis that it is a cross-reacting allergen with other mammalian products validated.

57 citations

Journal ArticleDOI
TL;DR: The results confirm that TNBC has a unique metabolic profile that may be exploited for therapeutic intervention and unravels molecular processes that can be related to differences in the genesis and clinical evolution of these types of breast cancer.
Abstract: Better knowledge of the biology of breast cancer has allowed the use of new targeted therapies, leading to improved outcome. High-throughput technologies allow deepening into the molecular architecture of breast cancer, integrating different levels of information, which is important if it helps in making clinical decisions. microRNA (miRNA) and protein expression profiles were obtained from 71 estrogen receptor-positive (ER(+)) and 25 triple-negative breast cancer (TNBC) samples. RNA and proteins obtained from formalin-fixed, paraffin-embedded tumors were analyzed by RT-qPCR and LC/MS-MS, respectively. We applied probabilistic graphical models representing complex biologic systems as networks, confirming that ER(+) and TNBC subtypes are distinct biologic entities. The integration of miRNA and protein expression data unravels molecular processes that can be related to differences in the genesis and clinical evolution of these types of breast cancer. Our results confirm that TNBC has a unique metabolic profile that may be exploited for therapeutic intervention.

57 citations

Journal ArticleDOI
08 May 2015-PLOS ONE
TL;DR: It is confirmed RSV disease is associated with wheezing in 32-35 wGA infants through 6 years of age and quality of life on the respiratory subscale of the TAPQOL was significantly lower and healthcare resource utilization was significantly higher in cases than controls.
Abstract: The health status of premature infants born 321-350 weeks’ gestational age (wGA) hospitalized for RSV infection in the first year of life (cases; n = 125) was compared to that of premature infants not hospitalized for RSV (controls; n = 362) through 6 years. The primary endpoints were the percentage of children with wheezing between 2-6 years and lung function at 6 years of age. Secondary endpoints included quality of life, healthcare resource use, and allergic sensitization. A significantly higher proportion of cases than controls experienced recurrent wheezing through 6 years of age (46.7% vs. 27.4%; p = 0.001). The vast majority of lung function tests appeared normal at 6 years of age in both cohorts. In children with pulmonary function in the lower limit of normality (FEV1 Z-score [-2; -1]), wheezing was increased, particularly for cases vs. controls (72.7% vs. 18.9%, p = 0.002). Multivariate analysis revealed the most important factor for wheezing was RSV hospitalization. Quality of life on the respiratory subscale of the TAPQOL was significantly lower (p = 0.001) and healthcare resource utilization was significantly higher (p<0.001) in cases than controls. This study confirms RSV disease is associated with wheezing in 32-35 wGA infants through 6 years of age.

57 citations

Journal ArticleDOI
TL;DR: Quality of life (QOL) is a concept assessing physical, psychological and social factors which are influencing the patients’ well being, and beyond physical impairments and metabolic effects from cancer, patients often suffer from psychological stress, such as depression.
Abstract: Quality of life (QOL) is a concept assessing physical, psychological and social factors which are influencing the patients’ well being. Cancer and its therapy induce severe metabolic changes associated with QOL impairment. These alterations contribute to an increased energy wasting and a decreased food intake. Besides, it may lead to tumoral cachexia due to the complex interactions between pro-inflammatory cytokines and the host metabolism. On the other hand, and beyond physical impairments and metabolic effects from cancer, patients often suffer from psychological stress, such as depression.

57 citations

Journal ArticleDOI
01 Jan 2015-Gut
TL;DR: Experimental evidence is provided of the correlation between the degree of MDR3 floppase activity and the clinical outcomes of PFIC3, and of the impact of ABCB4 mutations on these outcomes.
Abstract: Objective Progressive familial intrahepatic cholestasis type 3 (PFIC3) is a potentially lethal autosomal recessive liver disease associated with mutations in ABCB4 , the gene encoding the canalicular translocator of phosphatidylcholine MDR3. While some affected children benefit from ursodeoxycholic acid (UDCA) therapy, others evolve to end-stage liver disease. We aimed to evaluate whether these different outcomes are related to the impact of ABCB4 mutations. Design Six children with PFIC3 were investigated by sequencing of ABCB4 exons and flanking intron-exon boundaries and by immunohistochemistry. ABCB4 missense mutations were phenotyped in vitro by assessing their effects on MDR3 expression, subcellular localisation, and phosphatidylcholine-translocating activity. The resulting data were contrasted with the clinical outcomes. Results Eight distinct ABCB4 mutations were identified: one nonsense, one splicing and six missense mutations, four of which (G68R, T201M, P479L, D459H) affected MDR3 expression level. G68R and D459H also led to retention of the protein in endoplasmic reticulum. Phosphatidylcholine efflux assays indicated that T201M, P479L, S978P and E1118K mutations impaired MDR3 activity to variable degrees. Three children with mutations that caused a total loss of MDR3 expression/function manifested progressive liver disease refractory to UDCA treatment. This was also the case in a patient carrying two different mutations that, in combination, resulted in a 90% reduction in total MDR3 activity. A favourable response to UDCA was achieved in two patients with estimated MDR3 activities of 50% and 33%, respectively. Conclusions These data provide experimental evidence of the correlation between the degree of MDR3 floppase activity and the clinical outcomes of PFIC3.

57 citations


Authors

Showing all 9020 results

NameH-indexPapersCitations
Jaakko Tuomilehto1151285210682
Vincent Soriano8776234084
Lina Badimon8668235774
Francisco J. Blanco8478933319
Michael A. Gatzoulis8247832562
Jose Lopez-Sendon8146041809
Victor Moreno8063531511
Joaquín Dopazo7539624790
Fernando Rodríguez-Artalejo7451223296
José R. Banegas7442128249
Michael Becker7231718189
Gianfranco Ferraccioli7040226515
Maria-Victoria Mateos6648024278
Manuel Romero-Gómez6442019006
Eulogio García6327015354
Network Information
Related Institutions (5)
Carlos III Health Institute
30K papers, 849K citations

84% related

University of Navarra
26.6K papers, 747.2K citations

83% related

Autonomous University of Barcelona
80.5K papers, 2.3M citations

80% related

University of Barcelona
108.5K papers, 3.7M citations

80% related

University Medical Center Groningen
30.3K papers, 967K citations

80% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202322
202272
20211,335
20201,186
2019889
2018670